To STING pathway targeting technologies market is projected to grow at an annualized rate of ~25%, till 2030

Roots Analysis has done a detailed study on STING Pathway Targeting Therapeutics and Technologies, 2020-2030.u201d covering key aspects of the industry and identifying future growth opportunities.<br><br>To order this 310 page report, which features 150 figures and 200 tables, please visit this link<br><br>Key Market Insights <br>uf0a7tMany small / macro molecule-based STING pathway modulators are currently being evaluated as monotherapies as well as in combination with other drugs<br>uf0a7tThe pipeline features candidates targeting different therapeutic areas and designed for administration through a variety of routes; majority of such therapeutics are being developed as third-line and second-line treatments<br>uf0a7tIn recent years, several well funded start-ups have entered this field of research, and are gradually developing proprietary products based on the STING pathway for the treatment of a variety of indications<br>uf0a7tIn addition, a number of big pharmaceutical players have also partnered with developers focused on STING targeting molecules in order to expand their respective capabilities in this upcoming field of pharmacology<br>uf0a7tPublished scientific literature indicates that both industry and academic players have made equal contributions to the innovation in this field; the major focus of such studies is presently on anti-cancer therapeutics<br>Contact Details<br>Gaurav Chaudhary<br> 1 (415) 800 3415<br>gaurav.chaudhary@rootsanalysis.com<br>

kevin987 + Follow